The Management of Lupus Nephritis – A Nephrologist’s Perspective

Join us on Tuesday, February 7, 2017 at Department of Medicine Grand Rounds for “The Management of Lupus Nephritis: A Nephrologist’s Perspective,” with Brad H. Rovin, MD, FACP, FASN (Professor of Medicine and Pathology; Lee A. Hebert Distinguished Professor of Nephrology; Director, Division of Nephrology; Vice Chairman of Medicine for Research, The Ohio State University, Wexner Medical Center).

Details:

  • Department of Medicine Grand Rounds
  • Tuesday, February 7, 2017
  • 12 p.m. (Noon)
  • Emory University Hospital Auditorium (2E)

About Brad H. Rovin, MD, FACP, FASN

Dr. Brad H. Rovin is director of the Division of Nephrology, vice chairman of medicine for research, and the Lee A. Hebert Distinguished Professor of Nephrology at the Ohio State University’s Wexner Medical Center. Dr. Rovin received his bachelor of science in chemical engineering from Northwestern University in Evanston, Illinois and received an MD from the University of Illinois Medical School in Chicago. He completed a residency in internal medicine at Barnes Hospital in St. Louis, Missouri and a fellowship in nephrology at Washington University School of Medicine (St. Louis). Dr. Rovin studies the pathogenesis of glomerular diseases, with a special interest in lupus nephritis. His research has focused on biomarker development for glomerular diseases. He also studies experimental therapeutics in an effort to find new treatments for glomerular diseases. Dr. Rovin established a multidisciplinary lupus, vasculitis, and glomerulonephritis clinic, and he directs an advanced fellowship autoimmune disease program for nephrologists and rheumatologists.

Related Links

About the Author

Emory Department of Medicine
The Department of Medicine, part of Emory University's School of Medicine, promotes excellence in education, patient care, and clinical and basic research.

Be the first to comment on "The Management of Lupus Nephritis – A Nephrologist’s Perspective"

Leave a comment

Your email address will not be published.




Share(s)